Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Malignant Pleural Mesothelioma
NCT00459862Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in malignant pleural mesothelioma (MPM), sponsored by National Cancer Institute. Started Mar 2007; status: completed.
02
Drugs
pazopanib
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00459862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459862.